Experimental modeling of behavioral disorders accompanying hashimoto’s thyroiditis by means of specific immunoglobulins

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Among the manifestations of Hashimoto’s autoimmune thyroiditis, there are various psychoneurological disorders. For more than a century, it has been known about psycho-neurological disorders associated with hypothyroidism, but along with that, there are also mental disorders in patients with thyropathies in euthyroid state. In 1966, Hashimoto’s encephalopathy was described, the pathogenesis and clear differential diagnostic criteria of which have not yet been determined. This article describes an experimental study in laboratory mice with intracisternal stereotaxic injection of IgG isolated from patients with autoimmune thyroiditis and comorbid depression or schizophrenia. A control group included animals receiving polyclonal IgG from healthy donors. Then behavioral tests were carried out, which revealed the characteristics and changes in behavior in the operated animals. Thus, animals that received immunoglobulins from patients with autoimmune thyroiditis and depression were less active in relation to the development of risk behavior. Porsolt’s tests on the 4th and 15th days after surgery showed that, regardless of the kind of the injected solutions, there was a change in the temporal relationships between the behavior patterns. In mice received IgG from patients with autoimmune thyroiditis and schizophrenia during the delayed Porsolt test, the ratio of the forms of motor activity shifted towards passive swimming. The mice received IgG from healthy donors did not demonstrate this change.

About the authors

Polina A. Sobolevskaia

Saint Petersburg State University

Author for correspondence.
Email: dr.polinasobolevskaia@bk.ru

Researcher

Russian Federation, Saint Petersburg

Anton N. Gvozdeckii

I.I. Mechnikov North-Western State Medical University, Ministry of Healthcare of the Russian Federation

Email: comisora@yandex.ru

Assistant Professor, Department of Psychiatry and Narcology

Russian Federation, Saint Petersburg

Vladimir J. Utekhin

Saint Petersburg State University; Saint Petersburg State Pediatric Medical University, Ministry of Healthcare of the Russian Federation

Email: utekhin44@mail.ru

MD, PhD, Associate Professor, Department of Pathologic Hpysiology Pcourses Immunopathology and Medical Informatics

Russian Federation, Saint Petersburg; Saint Petersburg

Evgenia V. Efimova

Saint Petersburg State University

Email: e.v.efimova@mail.ru

PhD, Senior Researcher

Russian Federation, Saint Petersburg

Savelii R. Kuvarzin

Saint Petersburg State University

Email: saveliy51@yandex.ru

младший научный сотрудник

Russian Federation, Saint Petersburg

Tamara V. Fedotkina

Saint Petersburg State University; Saint Petersburg State Pediatric Medical University, Ministry of Healthcare of the Russian Federation

Email: t.v.fedotkina@gmail.com

PhD, Associate Professor, Department of Histology and Embryology

Russian Federation, Saint Petersburg; Saint Petersburg

Leonid P. Churilov

Saint Petersburg State University; Saint Petersburg Scientific Research Institute of Phthisiopulmonology

Email: elpach@mail.ru

MD, PhD

Russian Federation, Saint Petersburg; Saint Petersburg

References

  1. Чурилов Л.П., Васильев А.Г. Патофизиология иммунной системы. – СПб.: Фолиант, 2014. – 664 c. [Churilov LP, Vasil’ev AG. Patophysiology of the Immune System. Saint Petersburg: Foliant, 2014. 664 p. (In Russ.)]
  2. Чурилов Л.П., Строев Ю.И., Ахманов М.С., Утехин В.И. Очерки истории медицины. – СПб.: Умный доктор, 2018. – C. 71–168. [Churilov LP, Stroev YuI, Axmanov MS, Utechin VJ. Essays on the History of Medicine. Saint Petersburg: Umnyj Doktor; 2018. P. 71-168. (In Russ.)]
  3. Asher R. Myxoedematous Madness. British Medical Journal. [Online] 1949;2(4627):555-562. Available from: https://DOI: 10.1136/bmj.2.4627.555 Accessed: 02.09.2021.
  4. Bogdanova OV, Kanekar S, D’Anci KE, Renshaw PF. Factors influencing behavior in the forced swim test. Physiol Behav. 2013;118:227-239. doi: 10.1016/j.physbeh.2013.05.012
  5. Brain WR, Jellinek EH, Ball K. Hashimoto’s disease and encephalopathy. Lancet. 1966;2(7462):512-514. doi: 10.1016/S0140-6736(66)92876-5
  6. Cantón A, de Fàbregas O, Tintoré M, et al. Encephalopathy associated to autoimmune thyroid disease: A more appropriate term for an underestimated condition? J Neurol Sci. 2000;176(1): 65-69. doi: 10.1016/s0022-510x(00)00302-6
  7. Castillo P, Woodruff B, Caselli R, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. 2006;63(2):197-202. doi: 10.1001/archneur.63.2.197
  8. Cribari-Neto F, Zeileis A. Beta Regression in R. Journal of Statistical Software. 2010;34:1-24. doi: 10.18637/jss.v034.i02
  9. Denninger JK, Smith BM, Kirby ED. Novel Object Recognition and Object Location Behavioral Testing in Mice on a Budget. Vis Exp. 2018;(141):10.3791/58593. doi: 10.3791/58593
  10. Kaidanovich-Beilin O, Lipina T, Vukobradovic I, et al. Assessment of Social Interaction Behaviors. J Vis Exp. 2011;(48):2473. doi: 10.3791/2473
  11. Kraeuter AK, Guest PC, Sarnyai Z. The Elevated Plus Maze Test for Measuring Anxiety-Like Behavior in Rodents. Methods Mol Biol. 2019;1916:69-74. doi: 10.1007/978-1-4939-8994-2_4
  12. Marshall GA, Doyle JJ. Long-term treatment of Hashimoto’s encephalopathy. J Neuropsychiatry Clin Neurosci. 2006;18(1):14-20. doi: 10.1176/jnp.18.1.14
  13. Matsunaga A, Yoneda M. Anti-NAE autoantibodies and clinical spectrum in Hashimoto’s encephalopathy. Rinsho Byori. 2009;57(3):271-278.
  14. Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: A review. Eur J Pharmacol. 2003;463(1-3):3-33. doi: 10.1016/s0014-2999(03)01272-x
  15. Rizopoulos D. GLMMadaptive: Generalized Linear Mixed Models using Adaptive Gaussian Quadrature. GLMMadaptive. 2019. Available from: https://drizopoulos.github.io/GLMMadaptive/reference/GLMMadaptive.html
  16. Mouse Brain Atlas. [Online] Available from: http://labs.gaidi.ca/mouse-brain-atlas/?ml=-1&ap=-0.4&dv =-2.2. Accessed: 02.09.2021.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Intraventricular injection of the experimental solutions: a – the animal is placed in the inhalation chamber filled with isoflurane vapors; b – exposure of the scalp under continuous supply of isoflurane; c – fixation of the animal in a stereotaxic setup with continuous supply of isoflurane, followed by craniotomy along the coordinates of the mouse stereotaxic atlas; d – fixation of the cannula in the trepanned animal brain followed by the introduction of experimental solutions; e – extraction from the stereotaxic device and reconstruction of the skin

Download (314KB)
3. Fig. 2. Open field test: a – distance moved; b – time spent in the central zone.

Download (124KB)
4. Fig. 3 . Social interaction test

Download (86KB)
5. Fig. 4. Open field with novel object test: a – distance moved; b – time of sniffing novel object; c – time, spent near known object; d – time, spent near novel object

Download (243KB)
6. Fig. 5. Elevated plus-maze test: a – time spent in the open arms of the maze; b – the number of manifestations of risk behavior (hanging by the animal from the open arms of the labyrinth). * р ≥ 0.04; ** р ≤ 0.006

Download (135KB)
7. Fig. 6. Porsolt forsed swimming test, day 4: a – time of active swimming; b – time of passive swimming; c – time of freezing

Download (117KB)
8. Fig. 7. Porsolt forsed swimming test, day 15: a – time of active swimming; b – time of passive swimming; c – time of freezing

Download (118KB)
9. Fig. 8. Time dynamics of the results of the Porsolt test by groups, from the 4th to the 15th day after the injection: a – active swimming time; b – fading time; c – time of passive swimming. Vertical lines – 95% confidence interval

Download (111KB)

Copyright (c) 2021 Sobolevskaia P.A., Gvozdeckii A.N., Utekhin V.J., Efimova E.V., Kuvarzin S.R., Fedotkina T.V., Churilov L.P.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies